Genenta Science SpA ADR
Quarterly Financials
| Values in thousands | 2023-12-31 |
|---|---|
Gross Profit | -41 |
EBITDA | -4,911 |
EBIT | -4,932 |
Net Income | -4,886 |
Free Cash Flow | -3 |
Cash | 3,691 |
Basic Shares | 18,216 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -41 | -6 | -5 | |
EBITDA | -9,719 | -11,690 | -11,037 | -5,682 |
EBIT | -9,764 | -11,732 | -11,043 | -5,687 |
Net Income | -8,912 | -11,645 | -8,477 | -5,529 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,244 | -11,218 | -7,445 | -6,967 |
Cash | 4,581 | 3,691 | 29,794 | 37,240 |
Basic Shares | 18,273 | 18,216 | 18,216 | 18,216 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.27 |
2021-03-31 | -$0.16 |
2020-12-31 | -$0.16 |
2020-09-30 | -$0.12 |
